药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Rosoxacin
Glycopyrronium
Bromocriptine may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.
Rosoxacin
Cycrimine
Bromocriptine may increase the central nervous system depressant (CNS depressant) activities of Cycrimine.
Rosoxacin
Methantheline
Bromocriptine may increase the central nervous system depressant (CNS depressant) activities of Methantheline.
Rosoxacin
Iobenguane
The therapeutic efficacy of Iobenguane can be decreased when used in combination with Bromocriptine.
Rosoxacin
Perphenazine
The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Perphenazine.
Rosoxacin
Azaperone
The therapeutic efficacy of Azaperone can be decreased when used in combination with Bromocriptine.
Rosoxacin
Thiothixene
The therapeutic efficacy of Thiothixene can be decreased when used in combination with Bromocriptine.
Rosoxacin
Molindone
The therapeutic efficacy of Molindone can be decreased when used in combination with Bromocriptine.
Rosoxacin
Chlorprothixene
The therapeutic efficacy of Chlorprothixene can be decreased when used in combination with Bromocriptine.
Rosoxacin
Mesoridazine
The therapeutic efficacy of Mesoridazine can be decreased when used in combination with Bromocriptine.
Rosoxacin
Chloride ion
Bromocriptine may increase the hypertensive and vasoconstricting activities of Chloride ion.
Rosoxacin
Terguride
Bromocriptine may increase the hypertensive and vasoconstricting activities of Terguride.
Rosoxacin
Levosalbutamol
Bromocriptine may increase the hypertensive and vasoconstricting activities of Levosalbutamol.
Rosoxacin
Vilanterol
Bromocriptine may increase the hypertensive and vasoconstricting activities of Vilanterol.
Rosoxacin
Nylidrin
Bromocriptine may increase the hypertensive and vasoconstricting activities of Nylidrin.
Rosoxacin
Salbutamol
Salbutamol may increase the hypertensive and vasoconstricting activities of Bromocriptine.
Rosoxacin
Lysergic acid diethylamide
Bromocriptine may increase the hypertensive and vasoconstricting activities of Lysergic acid diethylamide.
Rosoxacin
Dihydroergocristine
Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Bromocriptine.
Rosoxacin
Mirabegron
Mirabegron may increase the hypertensive and vasoconstricting activities of Bromocriptine.
Rosoxacin
Indacaterol
Indacaterol may increase the hypertensive and vasoconstricting activities of Bromocriptine.